In the present study, we attempted to assess whether uric acid could be used as a secondary marker in estimating the pregnancy risk associated with low birth weight in pregnancies requiring an sFlt-1/PlGF determination, i.e., those with a suspected or confirmed form of placental insufficiency. This evidence concerns the gene PGF and placental insufficiency.